UUSOP-13: Clinical Research Institutional Fee Schedule
Version Date: July 1, 2024
- Introduction and Purpose
- Definitions and Acronyms
- Fees
- Standard Fees
- Additional Fees
- Materials Required
- Document Approval
- Revision History
The scope and purpose of this SOP is to set forth requirements for the conduct of industry sponsored clinical trials within the University of Utah. This SOP may be used to guide the conduct of other types of clinical research studies to promote standardization and proper clinical research billing compliance practices.
Introduction and Purpose
The Clinical Research Institutional Fee Schedule is set forth as a standardized cost structure to be utilized when participating in industry sponsored research. Fee standardization within the University of Utah promotes consistency and assists in adhering to proper research billing compliance. Fees are inclusive of F&A unless otherwise stated.
Definitions and Acronyms
Clinical Research: Clinical research includes all research involving human participants. It does not include secondary studies using existing biological specimens or data collected without identifiers or data that are publicly available.
Clinical Trial: Clinical trials are clinical research studies involving human participants assigned to an intervention in which the study is designed to evaluate the effect(s) of the intervention on the participant and the effect being evaluated is a health-related biomedical or behavioral outcome.
CMS: | Centers for Medicare & Medicaid Services |
CTMS: | Clinical Trial Management System |
CTO: | Clinical Trials Office |
GCP: | Good Clinical Practice |
HIPAA: | Health Insurance Portability and Accountability Act |
IDE: | Investigational Device Exemption |
IDS: | Investigational Drug Services |
IND: | Investigational New Drug |
IRB: | Institutional Review Board |
PI: | Principal Investigator |
SAE: | Serious Adverse Event |
SIV: | Site Initiation Visit |
SOP: | Standard Operating Procedure |
- Standard fees (applicable to all protocols):
- Administrative Start-up:
- $6,750 one-time (minimal risk studies, i.e., observational, non-interventional, retrospective chart review)
- $10,800 one-time (all other studies)
- Clinical Trials Office Fee:
- $6,750 one-time (minimal risk studies)
- $12,000 one-time (all other studies)
- IRB Initial Submission and Review:
- $8,100 one-time (local)
- $5,100 (central)
- IRB Amendment Fee:
- $3,240 per occurrence (local – includes prep and submission)
- $2,040 (central)
- IRB Annual Review Fee:
- $2,560 annually (local – includes prep and submission)
- $1,360 annually (central)
- IRB Closeout Submission:
- $2,200 one-time
- CMS Coverage Analysis:
- $1,675 one-time (non-IDE trials)
- $2,184 one-time (IDE trials with sponsor submission to CMS)
- $4,095 one-time (IDE/IND trials with site submission to CMS)
- CTO/Department Maintenance:
- $2,500 quarterly
- Excessive Monitor Change:
- $1,425 (2nd change and each time thereafter)
- Monitoring Visit:
- $918 per day
- Remote Based Monitoring:
- $1,350 per event
- Pre-screening/Recruitment:
- $150 per hour
- 1.13. Outside Agency Audit (not for cause):
- $1,350 per day
- Participant Re-consent:
- $150 per occurrence
- Research Infrastructure Fee:
- $90 per hour
- Foreign Language Translation:
- $0.20 per word
- Foreign Language Onsite Interpretation:
- $150 per hour
- Principal Investigator Effort:
- $496 per hour
- Research Nurse Effort:
- $316 per hour
- Research Dietician Effort:
- $295 per hour
- Research Coordinator Effort:
- $170 per hour
- Document Archival and Storage:
- $675 per year (length of storage is per contract or protocol, whichever is longer)
- Site Closeout:
- $2,700 one-time
- Administrative Start-up:
- Additional fees (based on specifics of protocol)
- CTMS Fees (i.e., OnCore):
- $5,400 one-time start-up
- $2,700 annual maintenance
- IDS Pharmacy Setup:
- $4,860 one-time
- IDS Pharmacy Drug Destruction:
- $486 one-time at setup
- IDS Pharmacy Protocol Amendment:
- $284 per occurrence (Tier 1)
- $1,890 per occurrence (Tier 2)
- IDS Pharmacy Maintenance:
- $135 monthly (one drug)
- $68 monthly (per additional item)
- $250 per hour (if applicable)
- IDS Pharmacy Special Drug Handling:
- $1,013 one-time (if applicable)
- IDS Pharmacy Concomitant Medication Check:
- $304 per occurrence
- IDS Treatment Plan Development:
- $446 per oncology treatment arm (if applicable)
- IDS Pharmacy Special Monitoring:
- $743 one-time (if applicable)
- IDS Pharmacy Additional Paperwork:
- $122 per occurrence
- IDS Satellite Site Transfer fee:
- $156 per occurrence
- IDS Pharmacy Closeout:
- $1,047 one-time
- Laboratory Setup:
- $1,350 one-time
- Specimen processing management fee:
- $800-$1,600 quarterly
- Radiology Setup:
- $2,700 one-time
- Radiology Maintenance:
- $200 quarterly
- Radiological Drug Research Committee and Human Use Subcommittee:
- $2,300 one-time
- Phantom Imaging:
- $2,700 per scan
- De-identification/CD/Upload of Images:
- $150 per occurrence
- Shared Investigator Platform Setup
- $2,457 one-time
- Shared Investigator Platform Maintenance:
- $534 quarterly
- Ancillary Services Sponsor Required Protocol Training:
- $750 per occurrence
- Sponsor specific equipment maintenance & storage:
- $250 quarterly
- Safety Event Reporting and Follow-up:
- $621 per event
- Pregnancy Follow-up:
- $150 per hour
- IND External Safety Reports:
- $240 per report (after first 10 reports)
- Participant Travel Reimbursement:
- Current IRS business mileage rate plus F&A
- Participant Hotel Reimbursement:
- Up to $250 per night plus F&A
- Participant Payments:
- $2.05 Debit Card (initial)
- $1.10 Debit Card (per transaction)
- $2.70 Direct Deposit (per transaction)
- $2.05 Debit Card (replacement)
- Budget Translation Fee:
- $3,500 per protocol version
- Institutional Oversight Fee:
- $8,190 quarterly
- Primary Children’s Hospital Board Review:
- $2,089 one-time
- Center for Quantitative Cancer Imaging:
- $1,365 one-time
- CTSI Application Submission and Startup:
- $1,350 - $4,050 one-time
- Cell Therapy and Regenerative Medicine Startup:
- $4,725 one-time
- CTSI Biomedical Informatics Core 21 CRF Part 11 Compliance Maintenance:
- $3,375 one-time
- CTMS Fees (i.e., OnCore):
Materials Required
- UUSOP-13 Supplement A – Cost Structure Rationale
- Budget Process for Industry Trials – University of Utah Internal Only Guidance Document: https://qualitycompliance.research.utah.edu/budget-process-for-industry-trials/index.php
- Clinical Research Budget Training – University of Utah Research Education:
- Clinical Research Budget Development and the Importance of Clinical Research Billing Compliance: https://utah.catalog.instructure.com/browse/research-education/research-education-red/courses/red-online-clinical-research-budget-development-and-the-importance-of-clinical-research-billing-compliance
- Clinical Research Budget Negotiation: https://utah.catalog.instructure.com/browse/research-education/research-education-red/courses/red-online-clinical-research-budget-negotiation
- Clinical Research Budget Oversight: https://utah.catalog.instructure.com/browse/research-education/research-education-red/courses/red-online-clinical-research-budget-oversight
Document Approval
Erin Rothwell Ph.D.
Vice President for Research, University of Utah
DATE: July 5, 2024
Version Date |
Change Summary |
29Sep2021 |
Original Version |
31Jan2022 |
Updated to reflect F&A rate change |
21Mar2022 |
Specified "OnCore" as CTMS |
31Oct2022 25Jan2023 |
Addition of mandatory fees related to participant payment (i.e., 2.28) |
01Jul2023 |
Fiscal year 2024 rate and fee changes |
05Oct2023 |
Addition of CTSI Biomedical Informatics fee |
01Jul2024 |
Fiscal year 2025 rate and fee changes |